95 reports of this reaction
2.8% of all BENZALKONIUM CHLORIDE reports
#19 most reported adverse reaction
ARTHROPATHY is the #19 most commonly reported adverse reaction for BENZALKONIUM CHLORIDE, manufactured by Meijer, Inc.. There are 95 FDA adverse event reports linking BENZALKONIUM CHLORIDE to ARTHROPATHY. This represents approximately 2.8% of all 3,413 adverse event reports for this drug.
Patients taking BENZALKONIUM CHLORIDE who experience arthropathy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHROPATHY is a less commonly reported adverse event for BENZALKONIUM CHLORIDE, but still significant enough to appear in the safety profile.
In addition to arthropathy, the following adverse reactions have been reported for BENZALKONIUM CHLORIDE:
The following drugs have also been linked to arthropathy in FDA adverse event reports:
ARTHROPATHY has been reported as an adverse event in 95 FDA reports for BENZALKONIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHROPATHY accounts for approximately 2.8% of all adverse event reports for BENZALKONIUM CHLORIDE, making it a notable side effect.
If you experience arthropathy while taking BENZALKONIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.